SCHEMBL3418696

SCHEMBL3418696

CC(C#N)CCC[SiH](Cl)Cl

nearest known ligand 0.44

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3505090 0.86
SCHEMBL3629254 0.77 TSHR (0.60) TSHR
SCHEMBL3628455 0.77 TSHR (0.60) TSHR
SCHEMBL3630677 0.75 TSHR (0.57) TSHR
SCHEMBL28992501 0.75 TSHR (0.57) TSHR
SCHEMBL29273359 0.75 TSHR (0.57) TSHR
SCHEMBL2199511 0.74 TSHR (0.41) TSHR
SCHEMBL11802275 0.73
SCHEMBL28958677 0.72
SCHEMBL10932800 0.71 TSHR (0.67) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0987286-B1 Silicone gels and composites from sheet and tube organofunctional siloxane polymers DOW CORNING (US) 2004-07-14 EP claimed
EP-0987286-A2 Silicone gels and composites from sheet and tube organofunctional siloxane polymers DOW CORNING CORPORATION (US) 2000-03-22 EP claimed
US-6013705-A Silicone gels and composites from sheet and tube organofunctional siloxane polymers DOW CORNING CORPORATION (US) 2000-01-11 US claimed
US-20250326936-A1 ARTICLES INCLUDING SURFACE COATINGS AND METHODS TO PRODUCE THEM MAXTERIAL INC (US) 2025-10-23 US disclosed
US-12173166-B2 Articles including surface coatings and methods to produce them MAXTERIAL, INC. (US) 2024-12-24 US disclosed
US-20230295827-A1 COATINGS AND COATED SURFACES INCLUDING LOW-SURFACE ENERGY INORGANIC PARTICLES MAXTERIAL INC (US) 2023-09-21 US disclosed
US-11542621-B1 Coatings and coated surfaces including low-surface energy inorganic particles MAXTERIAL, INC. (US) 2023-01-03 US disclosed
EP-3691894-A1 ARTICLES INCLUDING SURFACE COATINGS AND METHODS TO PRODUCE THEM Maxterial, Inc. (US) 2020-08-12 EP disclosed
US-20190186035-A1 ARTICLES INCLUDING SURFACE COATINGS AND METHODS TO PRODUCE THEM MAXTERIAL INC (US) 2019-06-20 US disclosed
WO-2019067950-A1 ARTICLES INCLUDING SURFACE COATINGS AND METHODS TO PRODUCE THEM MAXTERIAL, INC. (US) 2019-04-04 WO disclosed
EP-3397788-A1 COATINGS AND COATED SURFACES WITH SELECTED SURFACE CHARACTERISTICS AND FEATURES Maxterial, Inc. (US) 2018-11-07 EP disclosed
US-20070032454-A1 Silsesquioxane derivative and production process for the same JNC CORPORATION (JP) 2007-02-08 US disclosed
US-7169873-B2 Silsesquioxane derivatives and process for production thereof CHISSO CORPORATION (JP) 2007-01-30 US disclosed
US-20050192708-A1 Method for selecting formulations to treat electrical cables NOVINIUM, INC. (US) 2005-09-01 US disclosed
US-20050189130-A1 Method for treating electrical cable at sustained elevated pressure NOVINIUM, INC. (US) 2005-09-01 US disclosed
US-20040249103-A1 Silsesquioxane derivatives and process for production thereof JNC CORPORATION (JP) 2004-12-09 US disclosed
EP-0987286-B1 Silicone gels and composites from sheet and tube organofunctional siloxane polymers DOW CORNING (US) 2004-07-14 EP disclosed
EP-1428795-A1 SILSESQUIOXANE DERIVATIVES AND PROCESS FOR PRODUCTION THEREOF CHISSO CORPORATION (JP) 2004-06-16 EP disclosed
EP-0987286-A2 Silicone gels and composites from sheet and tube organofunctional siloxane polymers DOW CORNING CORPORATION (US) 2000-03-22 EP disclosed
US-6013705-A Silicone gels and composites from sheet and tube organofunctional siloxane polymers DOW CORNING CORPORATION (US) 2000-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032454-A1 Silsesquioxane derivative and production process for the same KCNQ1, KCNQ2, KCNQ5 TSHR 4266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.